Email Updates

You are here

Home»Media

AVAC in the News

  • To Combat HIV, Sub-Saharan Africa Must Strengthen Its Data Management Systems

    In an interview on behalf of IFARA at CROI 2017, Kevin Fisher spoke with Ian Sanne and Kevin De Cock about HIV in sub-Saharan Africa.

    March 6, 2017
    BodyPro

  • Community Engagement in HIV Prevention Is a Disaster Management Plan

    In an interview on behalf of IFARA at CROI 2017, Morenike Ukpong-Folayan spoke with Mark Hubbard and Stacey Hannah about addressing community concerns regarding medical research.

    March 6, 2017
    BodyPro

  • How Access to HIV Treatment is Being Transformed Through Innovation

    One benefit of a “test and treat” approach is that it reduces the amount of virus in carriers’ bodies and so lowers their chances of passing it on. But despite big health benefits, the “test and treat” approach throws up new challenges for countries with large HIV epidemics.

    March 2, 2017
    Treatment
    The Guardian

  • Five HIV Patients Left 'Virus-Free' with No Need for Daily Drugs in Early Vaccine Trials

    A new vaccine-based treatment for HIV has succeeded in suppressing the virus in five patients, raising hopes further research could help prevent AIDS without the need for daily drugs. Researchers combined two innovative HIV vaccines with a drug usually used to treat cancer in the trial... After receiving the treatment, the virus was undetectable in five out of 24 participants and its spread was stopped by their immune systems, reported the New Scientist. One of them has been drug-free for seven months.

    February 24, 2017
    HIV Vaccine
    Independent

  • PEPFAR Trumps Politics: US advocates push to save global AIDS funding

    The battle to save the US President’s Emergency Plan for AIDS Relief (PEPFAR) is already well underway, just one month after President Donald J. Trump’s inauguration and his almost immediate reinstatement of the country's global gag order on foreign funding for comprehensive sexual health services.

    February 22, 2017
    General
    POZ

  • Jared Baeten—Aiming to See Off HIV

    “The last person that I train, I want that training to be in something other than HIV”, says Jared Baeten. Speaking to The Lancet Infectious Diseases from the HIV Research for Prevention Conference (HIVR4P) in Chicago, IL, USA, where he has brought a 12-strong team of his researchers, Baeten explains: “When that time comes, I want HIV to have been eliminated as public health threat, so we can focus on other diseases”.

    January 3, 2017
    Lancet

  • Voice of America on PEPFAR and Obama's Legacy

    Voice of America interviews AVAC’s Mitchell Warren about the success of PEPFAR under Obama and Bush. Listen and learn about the potential for continued success if this high-impact program gets robust funding under the next presidential administration.

    December 30, 2016
    General
    Voice of America

  • Boston Biotech Designs Pump to Prevent AIDS

    A Boston-based biotech company will partner with the Bill and Melinda Gates Foundation in a $140 million effort to prevent HIV in sub-Saharan Africa.

    December 30, 2016
    PrEP
    Boston Herald

  • Gates Foundation to Invest Up to $140 Million in HIV Prevention Device

    This Wall Street Journal article quotes AVAC's Mitchell Warren in this story about a promising innovation in HIV prevention: a match-stick size implantable drug pump for delivering PrEP.

    December 29, 2016
    PrEP
    The Wall Street Journal

  • 35 Years into the AIDS Epidemic, It's an Opportune but Precarious Time

    On the occasion of World AIDS Day, Devex interviews AVAC Executive Director Mitchell Warren to speak about best utilizing existing tools for treatment and prevention and the development of additional tools for the future.

    December 1, 2016
    General
    Devex

Pages